ERNEXA THERAPEUTICS INC COM
ERNEXA THERAPEUTICS INC COM is a security (CUSIP 114082308) tracked across SEC portfolio filings. 14 institutional managers reported $742K on Form 13F as of 2026-03-31; 2 registered fund positions totaling $5K via N-PORT as of 2026-03-31.
Summary
- Issuer: ERNEXA THERAPEUTICS INC
- Class: COM
- CUSIP: 114082308
- Asset category: EC
- 13F holders: 14
- 13F value: $742K
- 13F period: 2026-03-31
- N-PORT fund positions: 2
- N-PORT value: $5K
- N-PORT report: 2026-03-31
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| Bleichroeder LP | NEW YORK, NY | $398K | 2,000,000 |
| Dauntless Investment Group, LLC | Milford, MI | $122K | 612,443 |
| Corient Private Wealth LLC | Miami, FL | $87K | 438,093 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $49K | 244,446 |
| VANGUARD GROUP INC | Valley Forge, PA | $43K | 35,922 |
| XTX Topco Ltd | LONDON, X0 | $11K | 54,338 |
| Warberg Asset Management LLC | WINNETKA, IL | $10K | 50,000 |
| JANE STREET GROUP, LLC | NEW YORK, NY | $8K | 41,167 |
| CITADEL ADVISORS LLC | MIAMI, FL | $7K | 33,076 |
| UBS Group AG | Zurich, V8 | $4K | 21,233 |
| GOLDMAN SACHS GROUP INC | NEW YORK, NY | $3K | 16,631 |
| BlackRock, Inc. | New York, NY | $163 | 820 |
| BNP PARIBAS ARBITRAGE, SNC | PARIS, I0 | $2 | 10 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |
Top fund holders (N-PORT)
More